tyrosyl-isoleucyl-glycyl-seryl-arginine has been researched along with seryl-isoleucyl-lysyl-valyl-alanyl-valinamide in 1 studies
| Studies (tyrosyl-isoleucyl-glycyl-seryl-arginine) | Trials (tyrosyl-isoleucyl-glycyl-seryl-arginine) | Recent Studies (post-2010) (tyrosyl-isoleucyl-glycyl-seryl-arginine) | Studies (seryl-isoleucyl-lysyl-valyl-alanyl-valinamide) | Trials (seryl-isoleucyl-lysyl-valyl-alanyl-valinamide) | Recent Studies (post-2010) (seryl-isoleucyl-lysyl-valyl-alanyl-valinamide) |
|---|---|---|---|---|---|
| 111 | 0 | 29 | 17 | 0 | 5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hill-Bator, A; Opolski, A | 1 |
1 review(s) available for tyrosyl-isoleucyl-glycyl-seryl-arginine and seryl-isoleucyl-lysyl-valyl-alanyl-valinamide
| Article | Year |
|---|---|
[Biological activity of synthetic analogs of laminin active sequences: YIGSR, RGD, SIKVAV].
Topics: Animals; Antineoplastic Agents; Humans; Laminin; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasms; Neoplastic Processes; Neovascularization, Pathologic; Oligopeptides; Platelet Aggregation; Thrombosis | 2002 |